Table 1

Percentage of immunopositive cells in the tumour specimens and the tumour free specimens

TumourTumour free specimens
ParametersNo. positive (%) casesMedian % positive cells (range)*No. positive (%) casesMedian % positive cells (range)*
Also listed are the number and percentage of cases in which the immunopositive cells were raised above the defined cut off limits.
*Percentage of immunopositive cells/specimen.
EGFR, epidermal growth factor receptor; MVD, microvessel density; ND, not defined.
Number7966
EGFR32 (41%)3 (0–80)1 (2%)0 (0–1)
c-erbB-229 (37%)10 (0–80)3 (5%)1 (0–30)
c-erbB-346 (58%)20 (0– 80)3 (5%)0 (0–10)
bcl-226 (33%)10 (0–70)3 (5%)3 (0–20)
p5329 (37%)0.1 (0– 50)1 (2%)0 (0–5)
Ki-6736 (46%)1 (0–20)1 (2%)0 (0–10)
p12046 (58%)10 (0–50)5 (8%)0.1 (0–20)
MVD29 (37%)20 (0.1–50)ND